logo

Biotechnology & Drugs News

Share

KemPharm Announces Positive Topline Data From Phase 1 Trial Evaluating Cardiovascular Safety Of Serdexmethylphenidate

Cara Therapeutics Submits NDA In Japan For Approval Of Difelikefalin For Pruritus In Hemodialysis

Revive Therapeutics Provides Update On Phase 3 Clinical Trial For Bucillamine In COVID-19

PepGen Reports Positive Data From Phase 1 Trial Of PGN-EDO51 For Duchenne Muscular Dystrophy